Articles tagged with Myocardial Infarction
The American College of Cardiology has introduced Clinical Performance Measures to ensure eligible patients receive proven therapies, including aspirin prescription and cholesterol-lowering therapy. By implementing these measures, physicians and hospitals can improve healthcare quality and prepare for the future.
A recent study published in JAMA found that administering L-arginine to patients following a first ST-segment elevation myocardial infarction (STEMI) does not reduce vascular stiffness or improve ejection fraction. In fact, the study suggests that older patients taking L-arginine may be at an increased risk of death after a heart attack.
Researchers found that women have a similar risk of overall mortality and sudden cardiac death following a heart attack as men. ICD therapy reduced mortality risk in both genders, with benefits estimated at 43% for women and 34% for men, according to the re-analysis of the MADIT II study.
Researchers discovered that macrophages secreting a specific enzyme trigger the rupture of unstable plaques in arteries, leading to cardiovascular events. The study suggests targeting this enzyme may help stabilize precarious plaques and reduce the risk of heart attacks and strokes.
Researchers identified a significant increase in stroke risk after heart attack, with risks remaining high for up to three years. The study highlights the importance of monitoring patients and implementing preventative measures such as medication adherence, smoking cessation, and healthy lifestyle habits.
A study of 2,160 people who had heart attacks found a high risk of stroke in the first month after the heart attacks. Hospital care at home was shown to be feasible and cost-effective, with patients receiving similar quality of care as those hospitalized.
A study published in the American Journal of Medicine found that women with similar levels of heart disease as men reported milder symptoms and perceived their disease as severe less often. Researchers suggest this may contribute to differences in heart care delivery between genders.
A study of 4,975 patients found that short-term NSAID use does not increase the risk of heart attack. Long-term NSAID use, particularly for over a year, may slightly raise this risk. The findings also suggest individual NSAIDs have varying cardiovascular effects.
A major study by the European Society of Cardiology links chronic noise exposure to an increased risk of heart attacks, particularly in men and women under 70. The study found that general environmental noise increased risk by nearly 50% for men and three-fold for women, while workplace noise levels affected men's risk but not women's.
A study found that individuals with the shortest delays had a greater probability of experiencing the largest number of symptoms, including sweating, which may prompt them to seek treatment early. Those with longer delays had moderate probability of experiencing chest pain and shortness of breath
A study analyzing follow-up data from the SYNERGY trial found that enoxaparin and unfractionated heparin had similar death or nonfatal MI rates at six months, but mortality at one year was similar. Patients with high-risk ACS features remain at risk for continued adverse cardiac morbidity and mortality.
A survey found that nearly half of people with diabetes are not using aspirin as prescribed, despite its proven benefits in reducing heart attack and stroke risk. The study highlights the need for better communication between healthcare professionals and patients, particularly those with diabetes who are at higher risk.
A study of 5,700 patients found that carriers of a specific genetic variation had a 43% higher risk of death, heart attack, or stroke. The research aims to tailor drugs to individual patients based on their genetic makeup, potentially leading to safer and more effective treatments.
Darbepoietin showed significant protection to heart tissue and improved cardiac function when administered 1-2 hours or 24 hours after an ischemic event. The findings suggest potential for quick translation into clinical trials.
The PROactive study shows ACTOS significantly reduced the recurrence of heart attacks and acute coronary syndrome in high-risk patients with type 2 diabetes. The medication demonstrated a 28 percent reduction in fatal or non-fatal heart attacks, as well as a 37 percent risk reduction in acute coronary syndrome.
A two-year study involving over 2,500 heart failure patients found that hospitals that cooperated to deliver proven care and educate patients saw lower death rates and rehospitalization rates. The project used a toolkit of standard admission orders, clinical pathways, and discharge checklists to ensure optimal care.
Researchers have discovered that stem cells derived from human heart tissue can develop into cardiospheres that express normal properties of primitive heart tissue. These cardiospheres were then grown in the laboratory and injected into mice with lab-induced heart attacks, where they migrated to damaged tissue and regenerated, improvin...
A study of 14,200 patients with type 2 diabetes found that fenofibrate reduced total CVD events by 11% due to a decrease in non-fatal heart attacks and bypass surgery. The drug was well-tolerated but associated with increased risks of pancreatitis and pulmonary embolism.
High doses of COX-2 inhibitors and other NSAIDs are associated with a higher risk of death, according to the study. Patients taking high doses of celecoxib or rofecoxib were found to be at a strikingly higher risk of death compared to those not taking NSAIDs.
Researchers found significant disparities in health status outcomes between African-Americans and whites, with blacks experiencing more angina, physical limitations, and poorer quality of life one year after an acute coronary syndrome. These disparities remained even after adjusting for hospital treatments and other factors.
A recent study found that obesity measured by waist-to-hip ratio is three times stronger than BMI in predicting the risk of heart attack. The researchers analyzed data from over 27,000 people across 52 countries and discovered a striking correlation between waist size and cardiovascular risk.
A recent study found that waist-to-hip ratio is a stronger predictor of heart attack than BMI in diverse ethnic populations. The researchers discovered that larger waist size was harmful, while larger hip size was protective, leading to substantial reassessment of obesity's importance for cardiovascular disease worldwide.
A new drug, clopidogrel, has been shown to significantly reduce deaths from heart attacks, with a 9% decrease in mortality rates compared to placebo. The treatment also resulted in a 14% reduction in repeat heart attacks during the study period, highlighting its potential to save thousands of lives each year.
A study of 11,481 childhood cancer survivors found that 20% had physical performance limitations compared to 12% of their siblings. Rehabilitation programs improved survival rates after heart attacks by reducing subsequent heart attacks by 17%.
Researchers have made a breakthrough in cardiac regeneration using bone marrow stem cells, improving left ventricular function and reducing infarct size in patients with old myocardial infarction. The therapy is safe, simple, and shows promising results, paving the way for larger trials to confirm its effectiveness.
Patients taking ASA plus dipyridamole had increased rates of myocardial infarction, but the addition of dipyridamole is rarely justified for stroke prevention. ASA remains the gold standard treatment for preventing stroke in high-risk patients.
A study found that drug-eluting stents significantly reduce the risk of restenosis in vein grafts, cutting heart attack rates by fourfold compared to bare metal stents. The treatment also decreases repeat procedures and death rates, suggesting a long-term advantage for patients with worn and diseased vein grafts.
In a randomized study, animals received injections of their own adipose stem and regenerative cells after a simulated heart attack. This approach resulted in a statistically significant reduction in perfusion defects and improved ejection fraction.
A large multicenter randomized study involving 384 patients found the CYPHER Stent to have a superior safety profile compared to intravascular brachytherapy. The study showed lower incidence of target vessel failure and major adverse cardiac events with the CYPHER Stent at nine-month follow-up.
Physicians at Providence Hospital have developed an early triage system using cell phones and ECGs to quickly transmit tracing data from paramedics in the field to emergency rooms, reducing average door-to-balloon time from 88 to 44 minutes.
A study published in Alcoholism: Clinical & Experimental Research found that moderate drinking is associated with lower levels of stickiness in platelets, which can lead to fewer blood clots. The research, conducted on over 1,000 participants, suggests that moderate alcohol consumption may have a protective effect against cardiovascula...
A study published in The Lancet found that pioglitazone reduces the risk of cardiovascular events in patients with type 2 diabetes. The treatment group experienced fewer adverse events and a lower risk of death from heart failure compared to the placebo group.
An international study found that 21% of coronary patients continued to smoke, with younger patients and those with angina less likely to quit. The survey highlights the need for more effective smoking cessation programs, particularly among younger patients and those with lower education levels.
Researchers at Yale University found innovative approaches to ensuring rapid treatment of patients, including management techniques and flow charts. The study identified key success factors for improving quality care in hospitals, with a focus on proper organization, planning, and communication.
A new study published in the Journal of the American College of Cardiology found that hospitals using quality-improvement tactics reduced heart attack death rates by 21-26%. The effort involved a checklist to ensure patients received crucial treatments and lifestyle advice, leading to improved patient outcomes.
A study of top-performing hospitals reveals the importance of timely angioplasty treatment in heart attacks. Successful hospitals employ a range of strategies to meet the 90-minute door-to-balloon time standard, including pre-hospital ECGs and collaborative teamwork.
According to a recent review, approximately 15% of heart attack patients develop post-traumatic stress disorder (PTSD), which can lead to impairments in social functioning, vitality, and physical health. The study also identifies risk factors for PTSD in cardiovascular disease patients.
A large analysis of Medicare records suggests that aspirin is not harmful and may even lower mortality rates in patients with heart failure and coronary artery disease. However, the debate remains controversial, with some experts recommending limiting or avoiding aspirin use for these patients.
Cardiac stress testing reveals a significant association between exercise capacity and heart rate recovery with CHD mortality rates. The study found that asymptomatic individuals with below-average test scores were two to four times more likely to die from CHD within 10-20 years.
The PROactive study shows that ACTOS significantly improves cardiovascular outcomes by reducing heart attacks, strokes, and death in high-risk patients. The study found a 16% reduction in life-threatening events and significant improvements in lipid profiles, blood pressure, and insulin resistance.
A review by Devereaux and colleagues highlights the risks of non-cardiac surgery, with 500,000 to 900,000 patients experiencing cardiac events each year. The authors discuss methods for estimating risk pre-operatively and communicating these findings to clinicians.
A new study reveals that women who suffer from heart attacks are more likely to experience longer hospital delays compared to their male counterparts. The study, which analyzed data from six major hospitals in Dublin, found that women were medically assessed an average of 30 minutes after arrival, while men received medical attention i...
A study of 3779 patients found women were 20% less likely to undergo an exercise test or angiography due to suspected coronary obstruction. Despite proven coronary disease, women received less aggressive treatment and were twice as likely to die or suffer a heart attack compared to men.
Researchers from Norway found that treating patients with high doses of B vitamins after a heart attack does not prevent recurrent heart disease or stroke. In fact, high doses of B vitamins may increase the risk of cardiovascular disease, particularly among those with impaired renal function.
The article highlights the significant disparity in cardiovascular disease (CVD) knowledge and treatment among European women. Women are more likely to develop CVD ten years after men, but it is also more lethal when it occurs suddenly, such as one year after a heart attack.
A new study has shown that fondaparinux, a synthetic drug, is as effective as traditional therapy in preventing heart attacks and ischemia while reducing major bleeding risks. Patients with acute coronary syndromes who received fondaparinux had lower mortality rates at one month and six months compared to those receiving enoxaparin.
The OASIS-5/MICHELANGELO study found fondaparinux to be as effective as enoxaparin in preventing heart attacks and death at nine days after an event, but demonstrated a dramatic reduction in major bleeding. Patients also had a lower mortality rate at six months.
A new study published in the JAMA Network found that clopidogrel pretreatment significantly reduced the odds of cardiovascular death, heart attack, or stroke following PCI by 46% compared to treatment at the time of PCI. Pretreatment also resulted in a 41% reduction in cardiovascular death from randomization through 30 days.
Research by Dr Andrew Lawrence and Cameron McPherson found adolescent rats exposed to amphetamine had a more sensitised reaction when re-administered as adults, increasing the risk of heart attack. The study suggests teenage experimentation with drugs may have long-term effects on brain function.
A new study published in the American Journal of Cardiology found that early statin therapy can significantly reduce mortality and other complications in heart attack victims. Patients who received statins before or within 24 hours of hospitalization had a 54% lower risk of in-hospital mortality, compared to those not on statin therapy.
New study finds that women and black patients with a heart attack are less likely to receive recommended treatments, including aspirin and reperfusion therapy. The researchers also found that cardiac catheterization was used less frequently in these patient groups.
Researchers at the Mayo Clinic have discovered that measuring C-reactive protein levels can help identify patients with stiffened arteries, which increases the risk of heart attack and stroke. The study suggests that suppressing low-grade inflammation may be a potential target for improving arterial health.
A new epidemiological study from the University of Pennsylvania School of Medicine found a protective relationship between non-aspirin, non-steroidal drugs (NANSAIDs) and heart attacks. The study used patient surveys instead of administrative databases, which may have skewed previous results.
A new study finds that ethnic minorities in Scotland experience a 60-70% higher incidence of heart attacks compared to non-South Asians. Poorer socio-economic status, environmental factors, barriers to healthcare, and genetic factors contribute to these disparities.
A study found persistent racial and gender disparities in heart attack care, with black women having lower rates of reperfusion therapy and higher in-hospital mortality rates compared to white men. The differences were not explained by patient characteristics, raising concerns about under-treatment.
A study by Yale University researchers found that delayed treatment for heart attacks treated outside regular hours leads to increased mortality rates. PCI therapy, which opens narrowed coronary arteries, is more effective when administered promptly, but delays result in reduced survival benefits.
A study of 372 community-dwelling older patients found that those receiving high-quality care had better survival rates than those without it. The research created a quality-of-care score based on 236 process-of-care measures, with survival improving steadily as the score increased.
Researchers followed 8527 people over 13 years to investigate the link between depression, fatigue, and cancer. Despite finding behaviors that increased cancer risk, they found no association between vital exhaustion scores and cancer risk.
A new review of the American College of Cardiology and American Heart Association guidelines aims to streamline diagnosis and treatment of acute coronary events. The goal is to provide faster treatment that may even prevent a heart attack or damage to the heart before it happens, benefiting millions of patients each year.
Researchers at Johns Hopkins Medicine have successfully treated heart attacks in animals using adult mesenchymal stem cells. The goal is to develop a widely applicable treatment to repair and reverse heart muscle damage caused by infarction.